Transcendent Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Transcendent Capital Group’s Portfolio XBI Stock Details XBI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2M	Buy
2024 Q4	–	Sell
2024 Q3	$11.9K	Sell
2024 Q2	$1.64M	Buy